financetom
Business
financetom
/
Business
/
SBI Life March quarter net rises 26% to Rs 672 cr
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SBI Life March quarter net rises 26% to Rs 672 cr
Apr 28, 2022 8:41 AM

SBI Life Insurance (SBI Life) on Thursday reported a 26.3 percent rise in its net profit at Rs 672 crore for quarter ended March 2022. The life insurer had posted a net profit of Rs 532 crore in the year-ago quarter.

Total income of the company during the January-March quarter of 2021-22 rose to Rs 21,427.88 crore, from Rs 20,896.70 crore in the same period of 2020-21, SBI Life said in a regulatory filing. Net premium income in Q4FY22 stood at Rs 17,433.77 crore, up by 12.07 percent from Rs 15,555.74 crore in the year-ago period.

For the full year 2021-22, the company's net profit grew to Rs 1,506 crore, as against Rs 1,456 crore in 2020-21. Income during the year rose to Rs 83,027.20 crore from Rs 82,084.89 crore a year ago. SBI Life said it registered a growth of 39 percent in the value of new business (VoNB) to Rs 3,700 crore in FY22.

Also Read

| Axis Bank Q4 results: Net profit jumps 54% YoY to Rs 4,117.8 crore, NII rises 17%; beats estimates

VoNB is the present value of expected future earnings from new policies written during a specified period. It reflects the additional value expected to be generated through the writing of new policies during a specified period. The insurer said it maintained private market leadership in individual rated premiums of Rs 12,870 crore, with 23.4 percent share.

There was strong growth in individual new business premium of 32 percent to Rs 16,500 crore in 2021-22 and strong growth in protection of new business premium of 24 percent to Rs 3,050 crore. New business premium (NBP) is the insurance premium due in the first policy year.

The company's 13th-month persistency ratio stands at 85.18 percent, it added. Persistency ratio reflects the number of policyholders who paid their renewal premium. Assets under management (AUM) grew by 21 percent to Rs 2.7 lakh crore as of March 31, 2022, SBI Life said.

Also Read | HDFC AMC Q4 results: Net profit grows 8.7% YoY to Rs 343.55 crore

SBI Life scrip closed at Rs 1,116.55 apiece on BSE, up by 3.99 percent from previous close.

First Published:Apr 28, 2022 5:41 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Zillow Sued by Compass Over Alleged Anticompetitive Listing Practices
Zillow Sued by Compass Over Alleged Anticompetitive Listing Practices
Jun 23, 2025
01:49 PM EDT, 06/23/2025 (MT Newswires) -- Zillow Group ( ZG ) (Z, ZG) has been sued by real estate brokerage Compass (COMP) for allegedly violating antitrust laws by using anticompetitive tactics to protect its monopoly and revenues, according to a lawsuit filed Monday in the US District Court for the Southern District of New York. Compass alleges that Zillow...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Metalex Ventures Finds
Metalex Ventures Finds "Promising" Drilling Results at B3 Claim Block
Jun 23, 2025
01:51 PM EDT, 06/23/2025 (MT Newswires) -- Metalex Ventures ( MXTLF ) Monday provided an update on the drilling at its B3 claim block in Quebec testing promising geophysical anomalies/ According to a company statement, at target 'O' Metalex ( MXTLF ) completed three holes testing a steeply-dipping, wide conductive zone associated with the northeast contact of a strong magnetic...
Impact BioMedical Stock Is Soaring Monday: What's Going On?
Impact BioMedical Stock Is Soaring Monday: What's Going On?
Jun 23, 2025
Impact Biomedical, Inc. ( IBO ) stock is trading sharply higher Monday after the company announced a limited merger and share exchange agreement with Dr. Ashleys. What To Know: Biopharmaceuticals developer Impact Biomedical ( IBO ) and Dr. Ashleys entered into a strategic merger agreement under which Dr. Ashleys will acquire Impact Biomedical ( IBO ) in a reverse merger....
Copyright 2023-2026 - www.financetom.com All Rights Reserved